If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
other |
total |
173
|
145
|
1
|
0 |
0 |
4
|
323
|
Gene and significance breakdown #
Total genes and gene combinations: 70
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
other |
total |
PKD1
|
46
|
24
|
0 |
4
|
74
|
COL4A5
|
15
|
13
|
0 |
0 |
28
|
PKHD1
|
12
|
15
|
0 |
0 |
27
|
COL4A4
|
11
|
12
|
0 |
0 |
23
|
COL4A3, MFF-DT
|
3
|
14
|
1
|
0 |
18
|
HNF1B
|
8
|
5
|
0 |
0 |
13
|
PKD2
|
8
|
1
|
0 |
0 |
9
|
NPHP3, NPHP3-ACAD11
|
6
|
2
|
0 |
0 |
8
|
TSC2
|
6
|
1
|
0 |
0 |
7
|
PAX2
|
5
|
1
|
0 |
0 |
6
|
WDR19
|
2
|
4
|
0 |
0 |
6
|
SLC12A3
|
3
|
2
|
0 |
0 |
5
|
ACE
|
3
|
1
|
0 |
0 |
4
|
COL4A1
|
2
|
2
|
0 |
0 |
4
|
COQ8B
|
1
|
3
|
0 |
0 |
4
|
CUBN
|
1
|
3
|
0 |
0 |
4
|
NPHP4
|
3
|
1
|
0 |
0 |
4
|
SLC7A9
|
1
|
2
|
0 |
0 |
3
|
TMEM67
|
1
|
2
|
0 |
0 |
3
|
TSC1
|
2
|
1
|
0 |
0 |
3
|
BBS12
|
1
|
1
|
0 |
0 |
2
|
CEP290
|
2
|
0 |
0 |
0 |
2
|
CLCNKB, LOC106501713
|
0 |
2
|
0 |
0 |
2
|
CLDN19
|
0 |
2
|
0 |
0 |
2
|
CPT2
|
1
|
1
|
0 |
0 |
2
|
CRB2
|
1
|
1
|
0 |
0 |
2
|
CTNS
|
2
|
0 |
0 |
0 |
2
|
HSD11B2
|
1
|
1
|
0 |
0 |
2
|
IFT122
|
0 |
2
|
0 |
0 |
2
|
IFT140
|
2
|
0 |
0 |
0 |
2
|
INVS
|
2
|
0 |
0 |
0 |
2
|
LOC107372315, OSGEP
|
0 |
2
|
0 |
0 |
2
|
MYO1E
|
1
|
1
|
0 |
0 |
2
|
NPHS2
|
2
|
0 |
0 |
0 |
2
|
PMM2
|
1
|
1
|
0 |
0 |
2
|
SLC3A1
|
0 |
2
|
0 |
0 |
2
|
SMARCAL1
|
1
|
1
|
0 |
0 |
2
|
TRPC6
|
1
|
1
|
0 |
0 |
2
|
TTC8
|
1
|
1
|
0 |
0 |
2
|
XPNPEP3
|
2
|
0 |
0 |
0 |
2
|
AQP2, AQP5
|
1
|
0 |
0 |
0 |
1
|
AVPR2
|
1
|
0 |
0 |
0 |
1
|
AXDND1, NPHS2
|
0 |
1
|
0 |
0 |
1
|
BBS1, ZDHHC24
|
0 |
1
|
0 |
0 |
1
|
CLCN5, LOC126863258
|
0 |
1
|
0 |
0 |
1
|
CLCNKB
|
1
|
0 |
0 |
0 |
1
|
CLDN16
|
0 |
1
|
0 |
0 |
1
|
DYNC2H1
|
1
|
0 |
0 |
0 |
1
|
EYA1
|
1
|
0 |
0 |
0 |
1
|
FGFR1
|
1
|
0 |
0 |
0 |
1
|
GREB1L
|
0 |
1
|
0 |
0 |
1
|
HNF1B, LOC126862549
|
0 |
1
|
0 |
0 |
1
|
IFT140, LOC105371046
|
1
|
0 |
0 |
0 |
1
|
INF2
|
0 |
1
|
0 |
0 |
1
|
ITGA8
|
1
|
0 |
0 |
0 |
1
|
JAG1
|
0 |
1
|
0 |
0 |
1
|
LMX1B
|
1
|
0 |
0 |
0 |
1
|
LOC107548112, REN
|
0 |
1
|
0 |
0 |
1
|
MUC1
|
1
|
0 |
0 |
0 |
1
|
MYH9
|
0 |
1
|
0 |
0 |
1
|
NEK8
|
0 |
1
|
0 |
0 |
1
|
NPHP1
|
1
|
0 |
0 |
0 |
1
|
NUP93
|
0 |
1
|
0 |
0 |
1
|
REN
|
1
|
0 |
0 |
0 |
1
|
RET
|
0 |
1
|
0 |
0 |
1
|
SLC12A1
|
0 |
1
|
0 |
0 |
1
|
SLC34A3
|
1
|
0 |
0 |
0 |
1
|
SLC4A1
|
0 |
1
|
0 |
0 |
1
|
TTC21B
|
0 |
1
|
0 |
0 |
1
|
UMOD
|
0 |
1
|
0 |
0 |
1
|
Condition and significance breakdown #
Condition |
pathogenic |
likely pathogenic |
uncertain significance |
other |
total |
Polycystic kidney disease, adult type
|
46
|
25
|
0 |
4
|
75
|
Autosomal recessive Alport syndrome
|
12
|
18
|
0 |
0 |
30
|
X-linked Alport syndrome
|
15
|
13
|
0 |
0 |
28
|
Autosomal recessive polycystic kidney disease
|
12
|
15
|
0 |
0 |
27
|
Renal cysts and diabetes syndrome
|
8
|
6
|
0 |
0 |
14
|
Autosomal dominant Alport syndrome
|
2
|
7
|
1
|
0 |
10
|
Nephronophthisis 3
|
6
|
2
|
0 |
0 |
8
|
Polycystic kidney disease 2
|
8
|
0 |
0 |
0 |
8
|
Tuberous sclerosis 2
|
6
|
1
|
0 |
0 |
7
|
Renal coloboma syndrome
|
5
|
1
|
0 |
0 |
6
|
Cystinuria
|
1
|
4
|
0 |
0 |
5
|
Familial hypokalemia-hypomagnesemia
|
3
|
2
|
0 |
0 |
5
|
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
|
2
|
2
|
0 |
0 |
4
|
Nephronophthisis 4
|
3
|
1
|
0 |
0 |
4
|
Nephrotic syndrome, type 9
|
1
|
3
|
0 |
0 |
4
|
Renal tubular dysgenesis
|
3
|
1
|
0 |
0 |
4
|
Bartter disease type 3
|
1
|
2
|
0 |
0 |
3
|
Nephronophthisis 11
|
1
|
2
|
0 |
0 |
3
|
Nephronophthisis 13
|
1
|
2
|
0 |
0 |
3
|
Nephrotic syndrome, type 2
|
2
|
1
|
0 |
0 |
3
|
Proteinuria, chronic benign
|
1
|
2
|
0 |
0 |
3
|
Saldino-Mainzer syndrome
|
3
|
0 |
0 |
0 |
3
|
Senior-Loken syndrome 8
|
1
|
2
|
0 |
0 |
3
|
Tuberous sclerosis 1
|
2
|
1
|
0 |
0 |
3
|
Apparent mineralocorticoid excess
|
1
|
1
|
0 |
0 |
2
|
Bardet-Biedl syndrome 12
|
1
|
1
|
0 |
0 |
2
|
Bardet-Biedl syndrome 8
|
1
|
1
|
0 |
0 |
2
|
Carnitine palmitoyl transferase II deficiency, neonatal form
|
1
|
1
|
0 |
0 |
2
|
Cranioectodermal dysplasia 1
|
0 |
2
|
0 |
0 |
2
|
Familial juvenile hyperuricemic nephropathy type 2
|
1
|
1
|
0 |
0 |
2
|
Focal segmental glomerulosclerosis 2
|
1
|
1
|
0 |
0 |
2
|
Focal segmental glomerulosclerosis 6
|
1
|
1
|
0 |
0 |
2
|
Focal segmental glomerulosclerosis 9
|
1
|
1
|
0 |
0 |
2
|
Galloway-Mowat syndrome 3
|
0 |
2
|
0 |
0 |
2
|
Infantile nephronophthisis
|
2
|
0 |
0 |
0 |
2
|
Joubert syndrome 5
|
2
|
0 |
0 |
0 |
2
|
Nephronophthisis-like nephropathy 1
|
2
|
0 |
0 |
0 |
2
|
Nephropathic cystinosis
|
2
|
0 |
0 |
0 |
2
|
PMM2-congenital disorder of glycosylation
|
1
|
1
|
0 |
0 |
2
|
Renal hypomagnesemia 5 with ocular involvement
|
0 |
2
|
0 |
0 |
2
|
Schimke immuno-osseous dysplasia
|
1
|
1
|
0 |
0 |
2
|
Alagille syndrome due to a JAG1 point mutation
|
0 |
1
|
0 |
0 |
1
|
Asphyxiating thoracic dystrophy 3
|
1
|
0 |
0 |
0 |
1
|
Autosomal dominant distal renal tubular acidosis
|
0 |
1
|
0 |
0 |
1
|
Autosomal recessive hypophosphatemic bone disease
|
1
|
0 |
0 |
0 |
1
|
Bardet-Biedl syndrome 1
|
0 |
1
|
0 |
0 |
1
|
Bartter disease type 1
|
0 |
1
|
0 |
0 |
1
|
Benign familial hematuria
|
0 |
1
|
0 |
0 |
1
|
Branchiootorenal syndrome 1
|
1
|
0 |
0 |
0 |
1
|
Dent disease type 1
|
0 |
1
|
0 |
0 |
1
|
Diabetes insipidus, nephrogenic, X-linked
|
1
|
0 |
0 |
0 |
1
|
Diabetes insipidus, nephrogenic, autosomal
|
1
|
0 |
0 |
0 |
1
|
Familial juvenile hyperuricemic nephropathy type 1
|
0 |
1
|
0 |
0 |
1
|
Focal segmental glomerulosclerosis 5
|
0 |
1
|
0 |
0 |
1
|
Hypogonadotropic hypogonadism 2 with or without anosmia
|
1
|
0 |
0 |
0 |
1
|
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
|
0 |
1
|
0 |
0 |
1
|
Nail-patella syndrome
|
1
|
0 |
0 |
0 |
1
|
Nephronophthisis 1
|
1
|
0 |
0 |
0 |
1
|
Nephronophthisis 12
|
0 |
1
|
0 |
0 |
1
|
Nephrotic syndrome, type 12
|
0 |
1
|
0 |
0 |
1
|
Primary hypomagnesemia
|
0 |
1
|
0 |
0 |
1
|
Proteinuria
|
0 |
1
|
0 |
0 |
1
|
Renal hypodysplasia/aplasia 1
|
1
|
0 |
0 |
0 |
1
|
Renal hypodysplasia/aplasia 3
|
0 |
1
|
0 |
0 |
1
|
Renal hypoplasia/aplasia
|
0 |
1
|
0 |
0 |
1
|
Renal-hepatic-pancreatic dysplasia 2
|
0 |
1
|
0 |
0 |
1
|
Tubulointerstitial kidney disease, autosomal dominant, 2
|
1
|
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.